1

Epratuzumab: A Deep Dive into the CD22 Antibody Treatment

News Discuss 
This agent is a novel therapeutic directed against CD22, the cell receptor found mainly on Lymphoid populations. This approach of action consists of inhibiting CD22-mediated pathways , as a https://amg41668679.wikiannouncement.com/user

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story